Zacks Research Initiates Coverage on Aeluma (NASDAQ:ALMU)

Stock analysts at Zacks Research started coverage on shares of Aeluma (NASDAQ:ALMU) in a note issued to investors on Tuesday, Zacks reports. The firm set a “hold” rating on the stock.

Several other equities research analysts also recently commented on the company. Weiss Ratings reissued a “sell (d-)” rating on shares of Aeluma in a report on Thursday, October 15th. Freedom Broker reduced their price target on Aeluma from $30.00 to $25.00 and set a “buy” rating for the company in a report on Thursday, September 17th. Finally, Northland Securities began coverage on Aeluma in a report on Monday. They set an “outperform” rating and a $16.00 price target for the company. One equities research analyst has rated the stock with a Strong Buy rating, four have issued a Buy rating, one has assigned a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat, the stock has an average rating of “Moderate Buy” and an average price target of $22.75.

Aeluma Stock Down 3.2%

Aeluma stock opened at $7.26 on Tuesday. The company has a market capitalization of $140.26 million, a P/E ratio of -13.96 and a beta of 4.52. The stock’s 50 day moving average is $11.17 and its 200 day moving average is $16.42. Aeluma has a twelve month low of $6.59 and a twelve month high of $31.79.

Aeluma (NASDAQ:ALMU) last posted its quarterly earnings data on Wednesday, September 16th. The company reported ($0.15) earnings per share for the quarter. The company had revenue of $0.58 million for the quarter. Aeluma had a negative net margin of 205.31% and a negative return on equity of 18.14%. As a group, equities analysts expect that Aeluma will post -0.57 EPS for the current year.

Insider Activity at Aeluma

In other news, Director Steven Denbaars sold 12,500 shares of the stock in a transaction that occurred on Wednesday, August 26th. The shares were sold at an average price of $13.84, for a total transaction of $173,000.00. Following the sale, the director owned 357,709 shares in the company, valued at $4,950,692.56. This represents a 3.38% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Also, CEO Jonathan Klamkin sold 100,000 shares of the firm’s stock in a transaction that occurred on Monday, October 12th. The shares were sold at an average price of $10.53, for a total transaction of $1,053,000.00. Following the sale, the chief executive officer directly owned 1,126,995 shares of the company’s stock, valued at $11,867,257.35. This trade represents a 8.15% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last quarter, insiders sold 212,500 shares of company stock worth $2,561,000. Insiders own 12.78% of the company’s stock.

Hedge Funds Weigh In On Aeluma

A number of hedge funds have recently added to or reduced their stakes in ALMU. BlackRock Inc. bought a new position in Aeluma in the 2nd quarter valued at approximately $21,489,000. Wedbush Securities Inc. boosted its stake in Aeluma by 586.0% during the 3rd quarter. Wedbush Securities Inc. now owns 352,775 shares of the company’s stock valued at $4,360,000 after purchasing an additional 301,350 shares during the last quarter. AWM Investment Company Inc. purchased a new stake in Aeluma during the 2nd quarter valued at $2,901,000. Bank of New York Mellon Corp purchased a new stake in Aeluma during the 2nd quarter valued at $2,047,000. Finally, Bank of America Corp DE bought a new stake in shares of Aeluma in the 2nd quarter worth $509,000.

Key Stories Impacting Aeluma

Here are the key news stories impacting Aeluma this week:

• Positive Sentiment: Northland Securities maintained an Outperform rating and a $16 price target, well above the reported $7.26 share price. Aeluma stock picked up by analysts at Northland Securities
• Neutral Sentiment: Zacks Research initiated coverage with a Hold rating, signaling a wait-and-see view rather than a clear catalyst for buying. Zacks Research ratings
• Negative Sentiment: Northland’s estimates still project losses, including a $0.57-per-share loss for FY2027 and $0.43 for FY2028. Persistent expected losses may weigh on sentiment, particularly as the stock is near its 12-month low. Northland Securities analyst coverage

Aeluma Company Profile

Aeluma, Inc is a semiconductor company developing technologies designed to manufacture high-performance compound semiconductor devices on large-diameter silicon substrates. Its approach is intended to combine the performance characteristics of compound semiconductors with the scalability and manufacturing infrastructure associated with silicon wafers.

The company’s technology is applicable to products such as photodetectors, light-emitting devices, laser components and other optoelectronic devices.